Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 13.035% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCC1CCc2c(sc(NC(C)=O)c2C#N)C1
b.) Cc1cc(C)c2c(CN3CCC(C)CC3)cc(=O)oc2c1C
c.) Cc1cc(C)nc(NC(=O)c2cccc([N+](=O)[O-])c2)c1
d.) S=C1NC2(CCCCCC2)N=C1c1ccccc1
Answer: b. Cc1cc(C)c2c(CN3CCC(C)CC3)cc(=O)oc2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c2c(CN3CCC(C)CC3)cc(=O)oc2c1C
Cc1cc(C)c2c(CN3CCC(C)CC3)cc(=O)oc2c1C
5,7,8-trimethyl-4-[(4-methylpiperidin-1-yl)methyl]chromen-2-one